Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Drug Discovery 8, 540 (1 July 2009) | doi:10.1038/nrd2931
Mood disorders: Channel inhibitor shows antidepressant potential
Abstract
The molecular mechanisms underlying human depression are still poorly understood. At present, most drug therapies for this disorder exert their effects by enhancing monamine neurotransmission, but the onset of symptom relief is slow, and many patients fail to achieve full remission.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
